Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 656

Stanford researchers develop molecule that forces cancer cells to kill themselves

The researchers’ recently published study describes a way to re-activate apoptosis in mutated cells, which would amount to forcing cancer to self-destruct through a bioengineered, bonding molecule.

Gerald Crabtree, one of the study’s authors and a professor of development biology, said he had the idea while hiking through Kings Mountain, California, during the pandemic period. The new compound would have to bind two proteins which already exist in the cancerous cells, turning apoptosis back on and making the cancer kill itself.

“We essentially want to have the same kind of specificity that can eliminate 60 billion cells with no bystanders,” Crabtree said, so that no cell gets destroyed if it isn’t the proper target of this new killing mechanism. The two proteins in question are known as BCL6, an oncogene which suppresses apoptosis-promoting genes in the B-cell lymphoma, and CDK9, an enzyme that catalyzes gene activation instead.

Your Standing Desk Might Actually Be as Bad as Sitting All Day

In recent years, standing has been touted as a remedy to a sedentary lifestyle, especially for desk workers who spend long hours seated at their screens.

But a new study from researchers in Australia and the Netherlands has found standing for long periods of time might not be much better than sitting after all – and actually comes with its own life-threatening risks.

Just under seven years of data from 83,013 adults were collected as part of the UK Biobank, using wrist-worn devices to track their activity, sleep, and sedentary time. The amount of time individuals spent standing and sitting was matched with incidences of cardiovascular diseases – coronary heart disease, heart failure and stroke – as well as circulatory diseases – low blood pressure on standing, varicose veins, chronic venous insufficiency, and venous ulcers.

Coarse-Grained Simulations of Adeno-Associated Virus and Its Receptor Reveal Influences on Membrane Lipid Organization and Curvature

Adeno-associated virus (AAV) is a well-known gene delivery tool with a wide range of applications, including as a vector for gene therapies. However, the molecular mechanism of its cell entry remains unknown. Here, we performed coarse-grained molecular dynamics simulations of the AAV serotype 2 (AAV2) capsid and the universal AAV receptor (AAVR) in a model plasma membrane environment. Our simulations show that binding of the AAV2 capsid to the membrane induces membrane curvature, along with the recruitment and clustering of GM3 lipids around the AAV2 capsid. We also found that the AAVR binds to the AAV2 capsid at the VR-I loops using its PKD2 and PKD3 domains, whose binding poses differs from previous structural studies. These first molecular-level insights into AAV2 membrane interactions suggest a complex process during the initial phase of AAV2 capsid internalization.

First data emerges from ‘direct-to-brain’ Alzheimer’s stem cell therapy trial

The small-scale FDA-cleared trial is designed to evaluate both the safety and initial efficacy of RB-ADSCs in nine patients with Alzheimer’s. Regeneration Biomedical’s CTAD presentation focused on the first three enrolled patients, who each received a single dose of RB-ADSCs delivered directly into the lateral ventricles of the brain using an “Ommaya reservoir” – a device implanted under the scalp to bypass the blood-brain barrier, a major obstacle in Alzheimer’s treatments.

Biomarker analysis at the 12-week mark demonstrated reductions in both p-Tau and amyloid-beta – two proteins strongly associated with Alzheimer’s disease progression. In cerebrospinal fluid (CSF) samples from the three patients, p-Tau levels decreased to “normal” levels, while amyloid PET scans also showed a reduction in amyloid buildup.

Regeneration Biomedical also reported its treatment produced signs of cognitive improvement, with two of the three patients showing increased Mini-Mental State Examination (MMSE) scores, a common measure of cognitive function.

Towards Fine-Tuned Control of Gene Expression

In a groundbreaking Nature paper, researchers have developed synthetic regulatory sequences that could prevent targeted gene therapies from having effects in unwanted cell types.

More than methylation

While methylation is the most well-known regulator of gene expression, it isn’t the only thing that determines what is to be expressed when. Cis-regulatory elements (CREs), so called because they sit near the DNA sequences they regulate, are responsible for expressing the genes that are specific to each cell type [1]. While they are technically non-coding, as they do not directly code for functional proteins, CREs are critical to epigenomic function.

Murata Goes Flexible with Its Stretchable Printed Circuit Platform

Murata is branching out from its usual ceramic components with the launch of flexible, stretchable electronics — a Stretchable Printed Circuit (SPC) platform it says is ideally positioned for wearable and medical devices.

In recent years, in the medical field, to make more accurate diagnoses, the…

Bendy, soft, stretchy devices target the wearable and medical markets.

Space-Born Stem Cells: A New Frontier in Regenerative Medicine

Dr. Abba Zubair, MD: “Our hope is to study these space-grown cells to improve treatment for age-related conditions such as stroke, dementia, neurodegenerative diseases and cancer.”

What can microgravity teach us about stem cell growth? This is what a recent study published in NPJ Microgravity hopes to address as a pair of researchers from the Mayo Clinic investigated past research regarding the growth properties of stem cells, specifically regeneration, differentiation, and cell proliferation in microgravity and whether the stem cells can maintain these properties after returning to Earth. This study holds the potential to help researchers better understand how stem cell growth in microgravity can be transitioned into medical applications, including tissue growth for disease modeling.

“The goal of almost all space flight in which stem cells are studied is to enhance growth of large amounts of safe and high-quality clinical-grade stem cells with minimal cell differentiation,” said Dr. Abba Zubair, MD, who is a faculty at the Mayo Clinic and the sole co-author on the study. “Our hope is to study these space-grown cells to improve treatment for age-related conditions such as stroke, dementia, neurodegenerative diseases and cancer.”

For the study, the researchers examined past research that launched stem cell cultures to the International Space Station (ISS) to have astronauts onboard evaluate the stem cells’ growth patterns and behavior under microgravity conditions. Dr. Zunair has launched stem cells to the ISS on three occasions and the various types of stem cells examined on the ISS in previous research include mesenchymal stem cells, hematopoietic stem cells, cardiovascular progenitor stem cells, and neural stem cells.

/* */